RTX Corporation
NYSE:RTXAerospace & Defense
-$7.28 today
- Market cap
- $266.45B
- Beta
- 0.31
- P/E (TTM)
- 34.4
- EPS (TTM)
- $5.38
- Dividend yield
- 1.49%
Volume 4.81M
Average 5.40M
RTX Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
RTX CorporationNYSE: RTX
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development growth accelerates
Q3 FY2026 research & development of $711M rose 3.9% year over year, ahead of the +1.0% change in trailing-twelve-month research & development. Sequentially, it fell 2.1% from the prior quarter. Over 3 fiscal years it compounded at +1.2% a year.
Context
- Research & development amounted to 3.2% of revenue in FY2025, down 0.5 pp from a year earlier.
- Research & development increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +3.9% holds above the trailing-twelve-month pace of +1.0%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 2.81B USD
- Year-over-year change
- -4.3%
- 4-year CAGR
- +0.7%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.81B | -4.3% |
| FY2024 | 2024-12-31 | 2.93B | +4.6% |
| FY2023 | 2023-12-31 | 2.81B | +3.5% |
| FY2022 | 2022-12-31 | 2.71B | -0.8% |
| FY2021 | 2021-12-31 | 2.73B | — |
Research & Development vs competitors
How RTX compares with its peers on the latest reported figures
- RTX's LTM Sep 2026 research & development of $2.85B is the 2nd highest of the 9 companies compared; the peer median is $462M.
- Its year-over-year change of +1.0% is the 3rd highest of 7, against a peer median of -7.8%.
- Research & development amounts to 3.0% of revenue for RTX, versus a peer median of 0.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $3.69B | -1.6% | +8.2% | 3.9% | |
| LTM Sep 2026 | $2.85B | +1.0% | +1.2% | 3.0% | |
| LTM Sep 2026 | $1.81B | +19.0% | +25.0% | 3.4% | |
| LTM Sep 2026 | $665M | — | +5.6% | 0.8% | |
| LTM Oct 2026 | $486M | -14.0% | +0.4% | 0.9% | |
| LTM Jul 2026 | $438M | +80.2% | -3.9% | 1.9% | |
| LTM Sep 2026 | $0 | -100.0% | -2.9% | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jul 2026 | $0 | -100.0% | — | 0.0% | |
| Peer median (excluding RTX) | $462M | -7.8% | +3.0% | 0.9% | |
Competitors are the stored peer set for RTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 64.39B | 67.07B | 68.92B | 80.74B | 88.6B |
| Cost of Revenue | 51.9B | 53.41B | 56.83B | 65.33B | 70.81B |
| Gross Profit | 12.49B | 13.67B | 12.09B | 15.41B | 17.79B |
| Gross Margin | 19.4% | 20.4% | 17.5% | 19.1% | 20.1% |
| Research & Development | 2.73B | 2.71B | 2.81B | 2.93B | 2.81B |
| Selling, General & Admin | 5.05B | 5.57B | 5.81B | 5.81B | 6.1B |
| Operating Expenses | 7.36B | 8.16B | 8.53B | 8.87B | 8.49B |
| Depreciation & Amortization | 4.56B | 4.11B | 4.21B | 4.36B | 4.38B |
| EBITDA | 11B | 11.53B | 9.7B | 12.53B | 14.95B |
| EBITDA Margin | 17.1% | 17.2% | 14.1% | 15.5% | 16.9% |
| Operating Income | 5.14B | 5.5B | 3.56B | 6.54B | 9.3B |
| Operating Margin | 8.0% | 8.2% | 5.2% | 8.1% | 10.5% |
| Interest Income | 36M | 70M | 100M | 102M | 98M |
| Interest Expense | 1.33B | 1.3B | 1.65B | 1.97B | 1.84B |
| Other Income / Expenses | (27M) | 613M | 275M | (344M) | (567M) |
| Income Before Tax | 5.11B | 6.12B | 3.84B | 6.19B | 8.73B |
| Pre-Tax Margin | 7.9% | 9.1% | 5.6% | 7.7% | 9.9% |
| Income Tax Expense | 964M | 790M | 456M | 1.18B | 1.66B |
| Net Income | 3.86B | 5.2B | 3.2B | 4.77B | 6.73B |
| Net Margin | 6.0% | 7.7% | 4.6% | 5.9% | 7.6% |
| EPS (Basic) | 2.57 | 3.52 | 2.24 | 3.58 | 5.02 |
| EPS (Diluted) | 2.56 | 3.50 | 2.23 | 3.55 | 4.96 |
| Weighted Avg Shares | 1.5B | 1.48B | 1.43B | 1.33B | 1.34B |
| Weighted Avg Shares (Diluted) | 1.51B | 1.49B | 1.44B | 1.34B | 1.36B |
RTX Corporation
NYSE:RTX
Intrinsic Alpha fair value
Locked
Current Price
$197.45
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.